The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.

 
Web www.patentalert.com

> Novel heterocyclic compounds as pSTAT3/IL-6 inhibitors

~ 00349